arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

InspireMD, Inc.

NSPR
$0.72 0.00 (0.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
16 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
13
Health
Poor
Bearish
auto_awesome

Analytical Summary

InspireMD, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $46.3M
Dividend Yield
Revenue Growth 28.1%
Op. Margin None
ROIC -90.0%
FCF / Share $-0.57
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 6, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.98M
↑ +28.1%
Net Income Profit after all expenses
$-48.79M
↓ -52.4%
Operating Margin Operating profit as % of sales
-478.0%
↓ -40.3%
FCF / Share Free cash flow per share
$-0.57
↓ -3.0%
Long-Term Debt Long-term obligations
$5.01M
↓ -1.5%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
0
Returns
10
Cash Quality
51

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 59 quarters